Technology area: Communications
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Hefei Raycision Medical Technology Co. Ltd. has 1 pending office action in the Communications technology area. This action is assigned to BLACKSTEN, SYDNEY LYNN, the sole distinct examiner for the company. With 1 distinct art unit involved, the current prosecution profile is limited to this single pending matter. This concentration means that the company's current success at the USPTO relies on the specific interpretation and feedback of a single official.
The busiest examiner, BLACKSTEN, SYDNEY LYNN, is responsible for 1 pending office action, which represents the full extent of the company's current active docket. This one-to-one relationship between the examiner and the pending action count simplifies the management of the portfolio but increases the impact of that single examiner's decisions. Practitioners should focus on the specific preferences and historical trends of this individual examiner within the Communications field.
Because there is only 1 distinct art unit, the technology is likely specialized within the communications domain. The absence of other pending actions or distinct examiners means there are no alternative prosecution paths currently active to offset any challenges encountered with this single application. This focused profile requires a precise and well-supported response to the 1 pending office action currently on record.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BLACKSTEN, SYDNEY LYNN | 1 | 100.0% | +0.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18966169 | DEEP LEARNING-BASED METHOD FOR GENERATING INTERNAL STRUCTURE OF ORGANISM | BLACKSTEN, SYDNEY LYNN | — |
| Art Unit | Apps |
|---|---|
| 2674 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18966169 | DEEP LEARNING-BASED METHOD FOR GENERATING INTERNAL STRUCTURE OF ORGANISM | BLACKSTEN, SYDNEY LYNN | 2674 | §103§112 | Non-Final OA | — | Pending | Dec 03, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialHefei Raycision Medical Technology Co. Ltd. has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Sydney Lynn Blacksten has the most, with 1 of Hefei Raycision Medical Technology Co. Ltd.'s pending office actions.
Mostly Communications (USPTO Tech Center 2600), based on where its pending office actions are examined.
